Description
ARA-290 (also known as Cibinetide) is an 11-amino-acid synthetic peptide engineered to selectively target and activate the innate repair receptor (IRR). Unlike native erythropoietin, ARA-290 does not stimulate red blood cell production (hematopoiesis), making it a key reference compound in preclinical studies focusing on tissue protection, cellular inflammation mitigation, and peripheral nerve repair.
In laboratory settings, ARA-290 is extensively evaluated for its potential to stimulate neurite outgrowth, reduce pro-inflammatory cytokine expression, and attenuate neuropathic signaling. Produced through advanced solid-phase peptide synthesis, this high-purity formulation maintains exceptional stability and consistency for rigorous in-vitro and in-vivo comparative research.
Product Specifications
| Specification | Details |
| Product Name | ARA-290 (Cibinetide) |
| Grade / Quality | High Purity Research Grade |
| Sequence / Structure | 11-Amino-Acid Synthetic Peptide |
| Purity Level | ≥ 98% (HPLC Tested) |
| Primary Application | Innate Repair Receptor (IRR) & Neuropathic Study |
| Form Factor | Lyophilized Powder |
| Storage Instructions | Store dry at -20°C away from light (reconstituted solution at 2°C – 8°C) |
| Compliance | For Laboratory & Research Use Only (RUO) |
Reviews
There are no reviews yet.